Find Reports
Select Report Type
Reimbursement Review
Displaying 826 - 850 of 1426
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| Abatacept | Orencia | Abatacept | Arthritis, rheumatoid | List with clinical criteria and/or conditions | Complete | SR0299-000 | |||
| Eculizumab | Soliris | Eculizumab | Hemolytic Uremic Syndrome, Atypical | Do not list | Complete | SR0304-000 | |||
| Adalimumab | Humira | Adalimumab | Arthritis, juvenile idiopathic | List with clinical criteria and/or conditions | Complete | SR0308-000 | |||
| Nebivolol | Bystolic | Nebivolol | Hypertension | Do not list at the submitted price | Complete | SR0307-000 | |||
| Tykerb Letrozole for Metastati... | Tykerb (in combination with Letrozole) | Lapatinib | Metastatic Breast Cancer | Do not reimburse | Complete | PC0019-000 | |||
| Telaprevir | Incivek | Telaprevir | Hepatitis C, chronic | List with criteria/condition | Complete | SF0311-000 | |||
| Boceprevir | Victrelis | Boceprevir | Hepatitis C, chronic | List with criteria/condition | Complete | SF0312-000 | |||
| Telaprevir | Incivek | Telaprevir | Hepatitis C, chronic | List with criteria/condition | Complete | SF0305-000 | |||
| Boceprevir | Victrelis | Boceprevir | Hepatitis C, chronic | List with criteria/condition | Complete | SF0303-000 | |||
| Palonosetron hydrochloride | Aloxi (injection) | Palonosetron hydrochloride | Chemotherapy-induced nausea and vomiting | Do not list at the submitted price | Complete | SR0293-000 | |||
| Elvitegravir/ Cobicistat/ Em... | Stribild | Elvitegravir/ Cobicistat/ Emtricitabine/ Tenofovir Disoproxil Fumarate | HIV infection | List with criteria/condition | Complete | SR0301-000 | |||
| Glycopyrronium bromide | Seebri | Glycopyrronium bromide | Chronic obstructive pulmonary disease | List with criteria/condition | Complete | SR0300-000 | |||
| Xalkori for Advanced NSCLC - R... | Xalkori | Crizotinib | Advanced or Metastatic Non-Small Cell Lung Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0017-000 | |||
| Palonosetron hydrochloride | Aloxi (capsule) | Palonosetron hydrochloride | Chemotherapy-induced nausea and vomiting | Do not list | Complete | SR0294-000 | |||
| Pirfenidone | Esbriet | Pirfenidone | Idiopathic pulmonary fibrosis | Do not list | Complete | SR0292-000 | |||
| Doxycycline monohydrate | Apprilon | Doxycycline monohydrate | Rosacea | Do not list | Complete | SR0279-000 | |||
| Collagenase clostridium histol... | Xiaflex | Collagenase clostridium histolyticum | Dupuytren’s contracture | List with criteria/condition | Complete | SR0287-000 | |||
| Velcade for Multiple Myeloma -... | Velcade | Bortezomib | Multiple Myeloma | Reimburse | Complete | PC0016-000 | |||
| Afinitor for Advanced Breast -... | Afinitor | Everolimus | Advanced Breast Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0014-000 | |||
| Ivacaftor | Kalydeco | Ivacaftor | Cystic fibrosis, G551D mutation | List with criteria/condition | Complete | SR0291-000 | |||
| Grass Pollen Allergen Extract | Oralair | Grass Pollen Allergen Extract | Allergic rhinitis | List with criteria/condition | Complete | SR0290-000 | |||
| Apixaban | Eliquis | Apixaban | Thromboembolic events prevention, (atrial fibrillation) | List with clinical criteria and/or conditions | Complete | SR0288-000 | |||
| Inlyta for metastatic renal ce... | Inlyta | Axitinib | Metastatic Renal Cell Carcinoma | Reimburse | Complete | PC0013-000 | |||
| Treanda for Chronic Lymphocyti... | Treanda | Bendamustine hydrochloride | Chronic Lymphocytic Leukemia (first-line) | Reimburse with clinical criteria and/or conditions | Complete | PC0011-000 | |||
| Tolvaptan | Samsca | Tolvaptan | Hyponatremia, non-hypovolemic | Do not list | Complete | SR0283-000 |
Health Technology Review
Displaying 601 - 602 of 602
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 826 - 850 of 2138
Please scroll or swipe to the right to view the full content.
| Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
|---|---|---|---|---|---|---|---|
| Vandetanib for Medullary Thyroid Cancer | Health Technology Review | Technology Review | Completed | HD0009-000 | |||
| selpercatinib | Reimbursement Review | Complete | PC0261-000 | ||||
| Tecovirimat for the Treatment of Human Monkeypox | Health Technology Review | Technology Review | Completed | HC0040-000 | |||
| Syphilis Screening for Adolescents and Adults | Health Technology Review | Rapid Review | Completed | RC1434-000 | |||
| Surveillance Colonoscopy Following Surgery for Colon Cancer | Health Technology Review | Summary of Abstracts | Completed | RB1623-000 | |||
| Intermittently Scanned and Real-Time Continuous Glucose Monitoring for People With Diabetes | Health Technology Review | Rapid Review | Completed | RC1436-000 | |||
| Infliximab for Graft versus Host Disease | Health Technology Review | Summary of Abstracts | Completed | RB1621-000 | |||
| Assessment of Postoperative Vital Signs Frequency | Health Technology Review | Summary of Abstracts | Completed | RB1620-000 | |||
| Removable Rigid Dressings for the Post-Operative Management of Leg Amputations | Health Technology Review | Summary with Critical Appraisal | Completed | RC1432-000 | |||
| Private IV Infusion Clinics in Canada | Health Technology Review | Environmental Scan | Completed | ES0365-000 | |||
| Intranasal Glucagon for the Treatment of Hypoglycemia | Health Technology Review | Summary with Critical Appraisal | Completed | RC1435-000 | |||
| Ibrutinib for Chronic Graft versus Host Disease | Health Technology Review | Summary with Critical Appraisal | Completed | RC1433-000 | |||
| Formulary Management of Targeted Immune Modulators for Ulcerative Colitis | Health Technology Review | Technology Review | In Progress | HD0010-000 | |||
| CADTH Pharmaceutical Reviews Update — Issue 30 | Reimbursement Review | Pharmaceutical Review Update | |||||
| Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastric, Gastroesophageal Junction (GEJ), or Esophageal Cancer | Reimbursement Review | Provisional Funding Algorithm | Complete | PH0010-000 | |||
| Stereotactic Ablative Radiotherapy for the Treatment of Oligometastatic Cancer | Health Technology Review | Completed | HT0029-000/HT0029-004 | ||||
| tralokinumab | Reimbursement Review | Complete | SR0689-000 | ||||
| inclisiran | Reimbursement Review | Complete | SR0681-000 | ||||
| prasterone | Reimbursement Review | Complete | SR0707-000 | ||||
| Alpha1-proteinase inhibitor (Human) | Reimbursement Review | Complete | ST0702-000 | ||||
| Utilization of Cholinesterase Inhibitors for Alzheimer’s Disease in Canada | Health Technology Review | Technology Review | Completed | HC0027-000 | |||
| Self-Collection of Nose and Throat Swab Samples for SARS-CoV-2 Antigen Testing | Horizon Scan | Emerging Health Technologies | Completed | EH0109-000 | |||
| Utilization of Old versus New Generation Biologics for Public and Private Insurers in Canada | Health Technology Review | Technology Review | Completed | HC0020-000 | |||
| Dapagliflozin for Chronic Kidney Disease | Health Technology Review | Rapid Review with Expert Input | RD0065-000 | ||||
| Melatonin for the Treatment of Insomnia in Children and Adolescents | Health Technology Review | Rapid Review | Completed | RC1423-000 |
Provisional Funding Algorithm
Displaying 76 - 81 of 81